期刊文献+

^(131)I治疗甲状腺功能亢进症

Different Dose ^(131)I to Treat Hyperthyroidism
暂未订购
导出
摘要 目的 探讨不同剂量13 1I治疗甲状腺功能亢进症的最佳治疗方法。方法  1998年 1月~ 2 0 0 1年12月 30 0例甲亢患者 ,平均随机分为三组 ,准确测定甲状腺TUK和EHL ,且EHL >3d ,甲状腺质量由核素显像确定 ,W =A×H×K。大剂量 (5 5 5MBq/g)组一次性全量 ;中剂量 (3 7MBq/ g)组一次性全量 ,3月后复查 ,酌情研究重复治疗或观察 ;小剂量 (2 5 9MBq/g)组 ,小剂量多次治疗 ,三个月为一疗程 ,直到治愈或好转。 结果 大剂量组 :治愈 94例 ,好转 6例 ,暂时性甲低 18例 ,永久性甲低 2 1例 ;中量组治愈 89例 ,11例好转 ,暂时性甲低 9例 ,永久性甲低 13例 ,1例 15个月后复发 ;小剂量组治愈 86例 ,14例好转 ,暂时性甲低 3例 ,永久性甲低 9例 ,4例复发。结论 13 1I治疗甲状腺功能亢进症效果肯定 ,治愈率高。三组治愈率 (χ2 =3 5 777,P >0 .0 5 )差别无显著性 ,而甲低发生率 (χ2 =6 0 6 0 ,P <0 .0 5 ) Objective To explore the best therapeutic method of different dose 131I to treat hyperthyroidism.Methods 300 hyperthyroidism cases were randomizedly divided into 3 groups from January 1998 to December 2001,and the thyroid TUR and EHL were measured accuratedly,and EHL>3d,W=A×H×R,thyroid quality was established by nucleatin development.Large dose group is 5.55MBq/g,and was given once full dose middle dose 3.7MBq/g,and was counterchecked after 3 months,and was retreated or observed by therapeutical situation;small dose group is 2.59MBq/g,with small dosage multitreatment.One course of treatment is 3 months and until cure or improvement.Results In large dose group 94 patients were cured and 6 patients were improved and transient hypothyreosis was 18 cases and 21 cases were permanent hypothyreosis,in middle dose group:89 cases cured,11 cases better,9 cases transcient hypothyreosis,13 cases permanent hypothyreosis,and one was recurrence after 15 months.In small dose group,86 cases were cured,14 patients were improved,transient hypothyreosis was 3 cases and 9 cases were permanent hypothyreosis,and 4 cases were recurrence.Conclusion The effectiveness is certain for 131I to treat hyperthyroidism with high cure rate.Three groups'cure rate (χ 2=3.5777,P>0.05)have no significant differene.Hypothyreosis ocurrennce rate (χ 2=6.060,P<0.05) have significant differene.
作者 谭涛 付玲
出处 《医药论坛杂志》 2004年第14期31-32,34,共3页 Journal of Medical Forum
关键词 ^131Ⅰ 放射治疗 甲状腺功能亢进症 有效半衰期 抗甲状腺药物 Iodine radioactivity isotope Hyperthyroidism Dose Individual dose
  • 相关文献

参考文献8

  • 1李少林.核医学,5版[M].北京:人民卫生出版社,2002.343.
  • 2Utigr. KD, The Thyroid, Sixth ed. Philadelphia, J. B.Lippincott Co,1991:887-916.
  • 3Shapiro B. J Nucl Med, 1993,34 : 1638-1641.
  • 4Sabri O, Zimny M, Schreckenberger M, et al. Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves ' disease Nuklearmedizin, 1998,37: 83-89.
  • 5Berg GEB, Michanek AMK, Holmberg ECV, et al.^131Ⅰ treatment of hyperhyroidism:Significance of effective half-life measurements. J Nucl Med, 1996,37 : 228-232.
  • 6O'Connor MK, Cullen MS, Malone JF, The value of a tracer dose in predicting the inetics of therapeutic doses of ^131Ⅰ in thyrotoxicoses. Br J Radiol,1979,52:719-726.
  • 7Sabri O, Zimny M, Schreckenberger M, et al. Succes srate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication, J Clin Endocinol Metab.1999.84:1229-1233.
  • 8张桂芝,卢倜章,谭建,刘华.抗甲状腺药物对^(131)I治疗甲亢疗效的影响[J].中华核医学杂志,2001,21(3):167-167. 被引量:35

二级参考文献2

  • 1谭天秩,核医学诊断与治疗规范,1997年,285页
  • 2谭建,中国地方病防治杂志,1996年,增刊,21页

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部